{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:28:06Z","timestamp":1784219286942,"version":"3.55.0"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["5UL1TR002389\u201302"],"award-info":[{"award-number":["5UL1TR002389\u201302"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rush Translational Sciences Consortium\/Swim Across America Organization"},{"name":"Brinson Foundation and Institute for Translational Medicine"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Pancreatic cancer (PC) rate is increasing in the U.S. The use of prescription and illicit opioids has continued to rise nationally in recent years as well. Opioids have been shown to have a deleterious effect on multiple types of cancer with recent data suggesting opium use as a risk factor for PC. Using national databases, we tested whether opioid usage pattern over time could explain the state and national-based variations in PC rates in the U.S. Opioid death rate (as a surrogate for prescription and illicit opioid use) was extracted from the CDCs Wonder online data through the Vital Statistics Cooperative Program. Incidence of pancreatic cancer was retrieved from the online CDCs data base gathered from the U.S. Cancer Statistics Working Group. Prevalence of obesity, tobacco and alcohol use was collected from Behavioral risk factor surveillance system. Mixed-effects regression models were used to test the association between levels of PC rate and opioid death\/use rates during the years 1999\u20132016. A rise in PC was seen over time at the national and state levels. Similarly, the opioid death rates increased over time. Among other potential PC risk factors, only obesity prevalence showed an increase during the study period. A state\u2019s opioid death rate at 4 years prior significantly predicted initial incidence of PC (\u03b2 = 0.1848, p&lt;0.0001) and had a significant effect on the estimated annual change in the rate of PC (\u03b2 = -.0193,p&lt;0.0001). Opioid use may be an un-identified risk factor contributing to the increasing incidence of PC in the U.S. These novel findings need to be verified by population-based studies.<\/jats:p>","DOI":"10.1371\/journal.pone.0244285","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T19:01:28Z","timestamp":1609959688000},"page":"e0244285","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Opioid use as a potential risk factor for pancreatic cancer in the United States: An analysis of state and national level databases"],"prefix":"10.1371","volume":"16","author":[{"given":"Usman","family":"Barlass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2853-4085","authenticated-orcid":true,"given":"Ameya","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faraz","family":"Bishehsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"pone.0244285.ref001","article-title":"Burden of Pancreatic Cancer-From Epidemiology to Practice","author":"N. Khalaf","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"pone.0244285.ref002","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"J. Kleeff","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"pone.0244285.ref003","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/MPA.0000000000001094","article-title":"Association Between Opioid Use and Survival Time in Patients With Unresectable Pancreatic Cancer: 10 Years of Clinical Experience","volume":"47","author":"T.K. Oh","year":"2018","journal-title":"Pancreas"},{"key":"pone.0244285.ref004","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMra0901557","article-title":"Pancreatic cancer","volume":"362","author":"M. Hidalgo","year":"2010","journal-title":"N Engl J Med"},{"key":"pone.0244285.ref005","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bpg.2017.09.001","article-title":"D. Consortium for the Study of Chronic Pancreatitis, C. Pancreatic, Tobacco and alcohol as risk factors for pancreatic cancer","volume":"31","author":"M. Korc","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"pone.0244285.ref006","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic adenocarcinoma","volume":"371","author":"D.P. Ryan","year":"2014","journal-title":"N Engl J Med"},{"key":"pone.0244285.ref007","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1158\/1055-9965.EPI-17-0592","article-title":"Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study","volume":"27","author":"S. Moossavi","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"pone.0244285.ref008","doi-asserted-by":"crossref","first-page":"e3922","DOI":"10.1097\/MD.0000000000003922","article-title":"Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer","volume":"95","author":"R. Shakeri","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"pone.0244285.ref009","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and Opioid-Involved Overdose Deaths\u2014United States, 2013\u20132017","volume":"67","author":"L. Scholl","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"pone.0244285.ref010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","article-title":"Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis","volume":"156","author":"K.E. Vowles","year":"2015","journal-title":"Pain"},{"key":"pone.0244285.ref011","unstructured":"C.f.D.C.a.P.a.N.C.I. U.S. Department of Health and Human Services, U.S. Cancer Statistics Working Group. U.S. Cancer Statistics Data Visualizations Tool, 2019, June."},{"key":"pone.0244285.ref012","unstructured":"N.C.f.H.S. Kaiser Family Foundation analysis of Centers for Disease Control and Prevention (CDC), Multiple Cause of Death 1999\u20132018 on CDC WONDER Online Database, 2020"},{"key":"pone.0244285.ref013","unstructured":"N.C.f.C.D.P.a.H.P. Centers for Disease Control and Prevention, Division of Population Health, BRFSS Prevalence & Trends Data."},{"key":"pone.0244285.ref014","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/MPA.0000000000000368","article-title":"Early detection of sporadic pancreatic cancer: summative review","volume":"44","author":"S.T. Chari","year":"2015","journal-title":"Pancreas"},{"key":"pone.0244285.ref015","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2307\/2529876","article-title":"Random-effects models for longitudinal data","volume":"38","author":"N.M. Laird","year":"1982","journal-title":"Biometrics"},{"key":"pone.0244285.ref016","doi-asserted-by":"crossref","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","article-title":"Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants\u2014United States","volume":"67","author":"P S.L. Seth","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"pone.0244285.ref017","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/MPA.0b013e318224056f","article-title":"Pain and opioid use in chronic pancreatitis","volume":"41","author":"S. Nusrat","year":"2012","journal-title":"Pancreas"},{"key":"pone.0244285.ref018","doi-asserted-by":"crossref","first-page":"e191827","DOI":"10.1001\/jamanetworkopen.2019.1827","article-title":"Factors Associated With Opioid Use in Patients Hospitalized for Acute Pancreatitis","volume":"2","author":"B.U. Wu","year":"2019","journal-title":"JAMA Netw Open"},{"key":"pone.0244285.ref019","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4251\/wjgo.v8.i8.599","article-title":"Road map for pain management in pancreatic cancer: A review","volume":"8","author":"M.J. Lahoud","year":"2016","journal-title":"World J Gastrointest Oncol"},{"key":"pone.0244285.ref020","unstructured":"N.I.o.D. Abuse, Addressing the Opioid Crisis Means Confronting Socioeconomic Disparities, (October 25, 2017)."},{"key":"pone.0244285.ref021","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/annonc\/mdw317","article-title":"Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer","volume":"27","author":"F. Janku","year":"2016","journal-title":"Ann Oncol"},{"key":"pone.0244285.ref022","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/mutage\/13.6.557","article-title":"Genetic toxicology of abused drugs: a brief review","volume":"13","author":"J.H. Li","year":"1998","journal-title":"Mutagenesis"},{"key":"pone.0244285.ref023","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1002\/cncr.29460","article-title":"The mu opioid receptor: A new target for cancer therapy?","volume":"121","author":"P.A. Singleton","year":"2015","journal-title":"Cancer"},{"key":"pone.0244285.ref024","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/0192623316679898","article-title":"Gut Homeostasis, Microbial Dysbiosis, and Opioids","volume":"45","author":"F. Wang","year":"2017","journal-title":"Toxicol Pathol"},{"key":"pone.0244285.ref025","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.trecan.2019.10.005","article-title":"Harnessing the Microbiome for Pancreatic Cancer Immunotherapy","volume":"5","author":"G.A. Vitiello","year":"2019","journal-title":"Trends Cancer"},{"key":"pone.0244285.ref026","volume-title":"Health and Medicine Division","author":"F.M. Phillips JK","year":"2017"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0244285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T19:01:53Z","timestamp":1609959713000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0244285"}},"subtitle":[],"editor":[{"given":"Ram K.","family":"Raghavan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0244285","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]}}}